Multiple sclerosis: open trials in Puerto Rico

• NCT07067463

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Caribbean Center for Clinical Research, Guaynabo

  Registry updated 2026-11-03

• NCT06433752

  A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  Research · TG Therapeutics, Inc.

  TG Therapeutics Investigational Trial Site, Guaynabo

  Registry updated 2026-10-30

• NCT07609719

  A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  Trial Treatment · Phase 4 · Genentech, Inc.

  Caribbean Center for Clinical Research, Guaynabo

  Registry updated 2026-10-30

• NCT06782490

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  Trial Treatment · Phase 2 · Celgene

  Puerto Rico Multiple Sclerosis Center, Caguas

  Registry updated 2026-10-27

• NCT07299019

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Caribbean Center for Clinical Research, Guaynabo

  Registry updated 2026-10-27

• NCT06408259

  Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Local Institution - 0134, Caguas

  Registry updated 2026-09-10

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error